403 related articles for article (PubMed ID: 8632406)
1. In vivo biodistribution, pharmacokinetic parameters, and brain uptake of 5-halo-y-methoxy(or ethoxy)-5,6-dihydro-3'-azido-3'-deoxythymidine diastereomers as potential prodrugs of 3'-azido-3'-deoxythymidine.
Wang L; Morin KW; Kumar R; Cheraghali M; Todd KG; Baker GB; Knaus EE; Wiebe LI
J Med Chem; 1996 Feb; 39(4):826-33. PubMed ID: 8632406
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, in vitro biological stability, and anti-HIV activity of 5-halo-6-alkoxy(or azido)-5,6-dihydro-3'-azido-3'-deoxythymidine diastereomers as potential prodrugs to 3'-azido-3'-deoxythymidine (AZT).
Kumar R; Wang L; Wiebe LI; Knaus EE
J Med Chem; 1994 Dec; 37(25):4297-306. PubMed ID: 7996541
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biodistribution of [4-14C]-5-bromo-6-methoxy-5,6-dihydro-prodrug derivatives of 5-ethyl-2'-deoxyuridine.
Cheraghali AM; Morin KW; Kumar R; Knaus EE; Wiebe LI
Drug Des Discov; 1994 Jul; 12(1):53-61. PubMed ID: 7578807
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antiviral (HIV-1, HBV) activities of 5-halo-6-methoxy(or azido)-5,6-dihydro-3'-fluoro-3'-deoxythymidine diastereomers. Potential prodrugs to 3'-fluoro-3'-deoxythymidine.
Kumar R; Wang L; Wiebe LI; Knaus EE
J Med Chem; 1994 Oct; 37(21):3554-60. PubMed ID: 7932583
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antiviral activity of 5-ethyl-5-halo-6-alkoxy-(or azido)-5,6-dihydro-2'-deoxyuridine diastereomers as potential prodrugs to 5-ethyl-2'-deoxyuridine.
Kumar R; Wiebe LI; Knaus EE
Arch Pharm (Weinheim); 1997 Aug; 330(8):259-63. PubMed ID: 9361522
[TBL] [Abstract][Full Text] [Related]
6. Accumulation of 5-ethyl-2'-deoxyuridine and its 5,6-dihydro prodrugs in murine lung and its potential clinical application.
Cheraghali AM; Morin KW; Kumar R; Knaus EE; Wiebe LI
J Pharm Pharmacol; 1995 Jul; 47(7):595-600. PubMed ID: 8568628
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and bioavailability of 5-ethyl-2'-deoxyuridine and its novel (5R,6R)-5-bromo-6-ethoxy-5,6-dihydro prodrugs in mice.
Cheraghali AM; Kumar R; Knaus EE; Wiebe LI
Drug Metab Dispos; 1995 Feb; 23(2):223-6. PubMed ID: 7736915
[TBL] [Abstract][Full Text] [Related]
8. Comparative pharmacokinetics of 3'-azido-3'-deoxythymidine (AZT) and 3'-azido-2',3'-dideoxyuridine (AZddU) in mice.
Doshi KJ; Gallo JM; Boudinot FD; Schinazi RF; Chu CK
Drug Metab Dispos; 1989; 17(6):590-4. PubMed ID: 2575492
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, biotransformation, pharmacokinetics, and antiviral properties of 5-ethyl-5-halo-6-methoxy-5,6-dihydro-2'-deoxyuridine diastereomers.
Cheraghali AM; Kumar R; Wang L; Knaus EE; Wiebe LI
Biochem Pharmacol; 1994 Apr; 47(9):1615-25. PubMed ID: 8185676
[TBL] [Abstract][Full Text] [Related]
10. Brain targeting of anti-HIV nucleosides: synthesis and in vitro and in vivo studies of dihydropyridine derivatives of 3'-azido-2',3'-dideoxyuridine and 3'-azido-3'-deoxythymidine.
Chu CK; Bhadti VS; Doshi KJ; Etse JT; Gallo JM; Boudinot FD; Schinazi RF
J Med Chem; 1990 Aug; 33(8):2188-92. PubMed ID: 2374145
[TBL] [Abstract][Full Text] [Related]
11. In vivo tissue disposition of 3'-azido-3'-deoxythymidine and its anabolites in control and retrovirus-infected mice.
Chow HH; Li P; Brookshier G; Tang Y
Drug Metab Dispos; 1997 Apr; 25(4):412-22. PubMed ID: 9107539
[TBL] [Abstract][Full Text] [Related]
12. Lymphatic distribution of 3'-azido-3'-deoxythymidine and 3'-azido-2',3'-dideoxyuridine in mice.
Manouilov KK; White CA; Boudinot FD; Fedorov II; Chu CK
Drug Metab Dispos; 1995 Jun; 23(6):655-8. PubMed ID: 7587948
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, in vitro anti-human immunodeficiency virus structure-activity relationships and biological stability of 5'-O-myristoyl analogue derivatives of 3'-azido-2',3'-dideoxythymidine (AZT) as potential prodrugs.
Parang K; Wiebe LI; Knaus EE
Antivir Chem Chemother; 1998 Jul; 9(4):311-23. PubMed ID: 9875410
[TBL] [Abstract][Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
[TBL] [Abstract][Full Text] [Related]
15. Conformational studies of novel antiretroviral analogs of zidovudine.
Baumgartner MT; Motura MI; Contreras RH; Pierini AB; Briñón MC
Nucleosides Nucleotides Nucleic Acids; 2003; 22(1):45-62. PubMed ID: 12708800
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and tissue distribution of (+/-)-3'-azido-2',3'-dideoxy-5'-O-(2-bromomyristoyl)thymidine, a prodrug of 3'-azido-2',3'-dideoxythymidine (AZT) in mice.
Parang K; Wiebe LI; Knaus EE
J Pharm Pharmacol; 1998 Sep; 50(9):989-96. PubMed ID: 9811159
[TBL] [Abstract][Full Text] [Related]
17. In vitro anti-hepatitis B virus activities of 5"-O-myristoyl analogue derivatives of 3"-fluoro-2",3"-dideoxythymidine (FLT) and 3"-azido-2",3"-dideoxythymidine (AZT).
Parang K; Wiebe LI; Knaus EE; Huang JS; Tyrrell DL
J Pharm Pharm Sci; 1998; 1(3):108-14. PubMed ID: 10948398
[TBL] [Abstract][Full Text] [Related]
18. Probing the mechanism of action and decomposition of amino acid phosphomonoester amidates of antiviral nucleoside prodrugs.
McIntee EJ; Remmel RP; Schinazi RF; Abraham TW; Wagner CR
J Med Chem; 1997 Oct; 40(21):3323-31. PubMed ID: 9341906
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and anti-HIV activity of steroidal prodrugs of 3'-azido-3'-deoxythymidine (AZT).
Balagopala MI; Ollapally AP; Lee HJ
Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S1-7. PubMed ID: 8574137
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo pharmacokinetic characterization of two novel prodrugs of zidovudine.
Quevedo MA; Briñón MC
Antiviral Res; 2009 Aug; 83(2):103-11. PubMed ID: 19549583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
